The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...

And what the heck is bio-convergence, anyway? It's where biology, engineering and artificial intelligence converge.

Fluidigm Corporation (NASDAQ:LAB), a company specializing in microfluidic systems for the life sciences industry with a market capitalization of $458 million, has seen its stock price touch a 52-week ...

A device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESSWIRE / 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whol ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

The Micro Immune Response On chip (MIRO) allows tumours and their environment to be replicated in order to understand their ...